Anthrax suspect commits suicide

A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked on developing an anthrax vaccine. He was also closely involved in analyzing samples from the 2001 attacks. Ivins's suicide comes just a month after the US government paid out $5.8 million to settle a lawsuit brought by linkurl:Steven J. Hatfill,;http://www.the-scientist.com/blog/display/54807/ a biodefense researcher and colleague of Ivins and long the unofficial primary suspect in the case despite the absence of clear evidence. According to the Times, Army officials had questioned Ivins in 2001 because he had failed to report anthrax contaminations found in his office between December 2001 and April 2002. Ivins claimed that the contamination resulted from a lab technician's accidental spills, and he was not disciplined for keeping the spills secret. Investigators began to focus their suspicions on Ivins after a new team of investigators took charge of the anthrax case in late 2006, and began reexamining old leads. "He buckled under government pressure," Ivins's brother told the Times. He had not been publically named as a suspect in the case, however. According to the linkurl:Associated Press;http://www.nytimes.com/aponline/us/AP-Anthrax-Scientist.html?ref=us&pagewanted=print, the FBI was investigating whether Ivins had released the anthrax in order to test a vaccine he had developed. Government officials are expected to announce in the next several days whether his death will mean the close the investigation, or whether they believe Ivins acted with others, the AP reports.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours